CD33 antibodies and use of same to treat cancer
US9587019B2 · kind B2 · utility
5Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2013 |
| Grant date | Mar 7, 2017 |
| Priority date | — |
| Expiry date | Aug 26, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.